Table 3 Level of expression of MYOD1, MYF5, MYOG and MSTN genes for PRGF group, Saline solution group and Control group (normal skeletal muscle)at 1 (T1), 2 (T2) and 4 (T4) weeks after treatment
Variable | Group | Treatment | Value (mean ± SD) |
|---|---|---|---|
MYOD1 | T1 | PRGF | 22,97 ± 2,86(+,*) |
Saline solution | 2,52 ± 0,27(+,*) | ||
Control | 0,90 ± 0,09 | ||
T2 | PRGF | 28,67 ± 5,76(+) | |
Saline solution | 26,39 ± 3,19(+) | ||
Control | 0,90 ± 0,10 | ||
T4 | PRGF | 45,25 ± 6,41(+) | |
Saline solution | 40,5 ± 5,29(+) | ||
Control | 0,90 ± 0,10 | ||
MYF5 | T1 | PRGF | 24,80 ± 4,52(+,*) |
Saline solution | 9,53 ± 1,08(+,*) | ||
Control | 0,78 ± 0,08 | ||
T2 | PRGF | 74,13 ± 10,38(+) | |
Saline solution | 78,36 ± 8,43(+) | ||
Control | 0,78 ± 0,08 | ||
T4 | PRGF | 81,69 ± 9,69(+) | |
Saline solution | 81,55 ± 7,54(+) | ||
Control | 0,78 ± 0,09 | ||
MYOG | T1 | PRGF | 23,43 ± 3,94(+,*) |
Saline solution | 8,36 ± 1,91(+,*) | ||
Control | 0,83 ± 0,08 | ||
T2 | PRGF | 31,87 ± 3,93(+) | |
Saline solution | 25,18 ± 3,79(+) | ||
Control | 0,85 ± 0,08 | ||
T4 | PRGF | 40,62 ± 8,16(+) | |
Saline solution | 31,87 ± 3,46(+) | ||
Control | 0.85 ± 0,08 | ||
MSTN | T1 | PRGF | 0,22 ± 0,03 |
Saline solution | 0,22 ± 0,04 | ||
Control | 0,76 ± 0,06 | ||
T2 | PRGF | 0,53 ± 0,10 | |
Saline solution | 0,81 ± 0,07 | ||
Control | 0,76 ± 0,06 | ||
T4 | PRGF | 0,75 ± 0,08 | |
Saline solution | 0,59 ± 0,11 | ||
Control | 0,76 ± 0,06 |